Robert S. Negrin

1.0k total citations
11 papers, 785 citations indexed

About

Robert S. Negrin is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Robert S. Negrin has authored 11 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Robert S. Negrin's work include Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Robert S. Negrin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Acute Myeloid Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Robert S. Negrin collaborates with scholars based in United States, Sweden and India. Robert S. Negrin's co-authors include Michael R. Verneris, Richard S. Stein, J W Vardiman, Peter L. Greenberg, Åke Öst, Eva Hellström‐Lindberg, Sanford B. Krantz, Martin Kornacker, Judith A. Shizuru and Ruby M. Wong and has published in prestigious journals such as New England Journal of Medicine, British Journal of Haematology and Cancer Immunology Immunotherapy.

In The Last Decade

Robert S. Negrin

11 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert S. Negrin United States 9 551 279 205 177 110 11 785
Claudia Rutt Germany 13 407 0.7× 285 1.0× 131 0.6× 75 0.4× 42 0.4× 22 664
Dipnarine Maharaj United States 12 316 0.6× 139 0.5× 230 1.1× 134 0.8× 57 0.5× 26 660
Jan Carneskog Sweden 16 492 0.9× 100 0.4× 95 0.5× 309 1.7× 137 1.2× 23 702
Giuseppe Irrera Italy 18 572 1.0× 136 0.5× 337 1.6× 94 0.5× 128 1.2× 51 828
Catherine Flynn Ireland 9 283 0.5× 94 0.3× 91 0.4× 139 0.8× 106 1.0× 33 538
Roy Baynes South Africa 13 294 0.5× 140 0.5× 145 0.7× 189 1.1× 107 1.0× 20 604
D Hollard France 13 432 0.8× 82 0.3× 118 0.6× 185 1.0× 102 0.9× 56 612
EC Guinan United States 9 365 0.7× 175 0.6× 200 1.0× 63 0.4× 92 0.8× 14 734
Elvira Deolinda Rodrigues Pereira Velloso Brazil 13 423 0.8× 88 0.3× 77 0.4× 209 1.2× 184 1.7× 81 654
Hind Rafei United States 13 290 0.5× 211 0.8× 271 1.3× 104 0.6× 168 1.5× 44 716

Countries citing papers authored by Robert S. Negrin

Since Specialization
Citations

This map shows the geographic impact of Robert S. Negrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Negrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Negrin more than expected).

Fields of papers citing papers by Robert S. Negrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Negrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Negrin. The network helps show where Robert S. Negrin may publish in the future.

Co-authorship network of co-authors of Robert S. Negrin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Negrin. A scholar is included among the top collaborators of Robert S. Negrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Negrin. Robert S. Negrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Yan, Hao, et al.. (2025). Engineered Invariant Natural Killer T Cells (iNKT cells) Targeting CD 117 As a Novel Treatment for Acute Myeloid Leukemia.. Transplantation and Cellular Therapy. 31(2). S201–S202. 1 indexed citations
2.
Verneris, Michael R., Maki Ito, Jeanette Baker, et al.. (2001). Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma. Biology of Blood and Marrow Transplantation. 7(10). 532–542. 85 indexed citations
3.
Kornacker, Martin, et al.. (2001). Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells. Immunology Letters. 76(3). 169–173. 53 indexed citations
4.
Verneris, Michael R., Martin Kornacker, Volker Mailänder, & Robert S. Negrin. (2000). Resistance of ex vivo expanded CD3 + CD56 + T cells to Fas-mediated apoptosis. Cancer Immunology Immunotherapy. 49(6). 335–345. 62 indexed citations
5.
Nash, Richard A., Razelle Kurzrock, John F. DiPersio, et al.. (2000). A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 6(1). 25–34. 67 indexed citations
6.
Kusnierz-Glaz, C., Robert S. Negrin, Judith A. Shizuru, et al.. (1999). Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biology of Blood and Marrow Transplantation. 5(5). 299–305. 52 indexed citations
7.
Ross, Maureen, G. Schmidt, Joyce C. Niland, et al.. (1999). Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: Effect on chronic graft-vs.-host disease and long-term survival. Biology of Blood and Marrow Transplantation. 5(5). 285–291. 21 indexed citations
8.
Hellström‐Lindberg, Eva, Robert S. Negrin, Richard S. Stein, et al.. (1997). Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. British Journal of Haematology. 99(2). 344–351. 216 indexed citations
9.
Chao, Nelson J., G. Schmidt, Joyce C. Niland, et al.. (1993). Cyclosporine, Methotrexate, and Prednisone Compared with Cyclosporine and Prednisone for Prophylaxis of Acute Graft-versus-Host Disease. New England Journal of Medicine. 329(17). 1225–1230. 211 indexed citations
10.
Schriber, Jeffrey & Robert S. Negrin. (1993). Use and Toxicity of the Colony-Stimulating Factors. Drug Safety. 8(6). 457–468. 15 indexed citations
11.
Negrin, Robert S., et al.. (1992). Therapy of Hematopoietic Disorders with Recombinant Colony-Stimulating Factors. Advances in pharmacology. 23. 263–296. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026